London–Bermuda connections celebrated at BDA forum
LONDON, Nov. 27, 2018 (GLOBE NEWSWIRE) -- Bermuda’s historic business bonds with London and potential future synergies through fintech and emerging technologies were key themes of a multi-industry forum in London today.
Close to 200 industry professionals from a range of business sectors—from shipping to insurtech—attended the Bermuda Executive Forum held at ME London by the Bermuda Business Development Agency (BDA). The event, the agency’s fourth overseas forum and second in London over the past year, brought together more than 50 senior industry and regulatory leaders as speakers and panellists to showcase the island as a financial centre of excellence. Presentations and discussions turned the spotlight on investment and business opportunities, and also underscored commonalities shared by the Bermuda and London markets.
“London is a very important market, and we want more people to know how we’re innovating and how we’re leading the charge,” said Premier David Burt who officially opened the forum. “Bermuda is different—we represent a place where you can develop products and services and sell them to the world from a well-regulated environment. We want to make sure that message is consistently heard.”
The UK’s Chris Holmes, Lord of Richmond MBE, joined the Premier for a 40-minute “fireside chat” on fintech to kick off the event, moderated by BDA Director Jessel Mendes. Holmes is a former Paralympic swimmer and nine-time Games gold-medal winner who has championed digital opportunities and the public benefits of blockchain and assistive technology since entering the House in 2013.
“London and Bermuda have had an extraordinary relationship over centuries, rooted in areas of the economy such as insurance, which continues to be such a close and fruitful bond for both parties,” noted Holmes. “When you look at all the opportunities fintech presents, it fits so well into that connection we have as two innovative jurisdictions, where we can collaborate, and where there can be niche areas for both entities. Working together, London and Bermuda can be key players in forging the potential future the Fourth Industrial Revolution offers.”
Throughout the day, industry professionals discussed the mature foundation and advantages Bermuda affords both established companies and startups, as well as its regulatory leadership and innovative culture that pioneered a legislative framework around fintech this year.
“Today’s forum was even bigger and better than our first one last year — an indication of the interest folks in London have about Bermuda,” said Mendes, an EY Bermuda Partner. “In talking with Lord Holmes and the Premier, clearly there’s a lot of common ground. Insurance has been a huge connection for a long time. And now, the same synergies apply to fintech. This is a dialogue we should continue.”
Attendees included former Bermuda Governor George Fergusson and other members of The Bermuda Society in London. “As keen supporters of the BDA’s efforts in London, we’re want to ensure we help cement ties between the City of London and Bermuda by creating opportunities for markets across the globe to understand the island as a sophisticated gateway,” said Sheba Raza, Counsel at Conyers UK and a Society Director. “We want to encourage opportunities for investors and international businesses as they seek to deploy capital and grow in a post-Brexit universe,” she added. “It allows us to ensure the UK and its family of territories operate in a cohesive, cooperative way to strengthen ties that exist already between our two countries.”
Euan Davis, of the Center for the Future of Work Europe at Cognizant Technology Solutions, was lunchtime keynote at today’s forum. He outlined “21 Jobs of the Future” as new technologies, business practices, and workers emerge over the next decade.
Eric Bertrand, founding partner of Centaur Fund Services, praised the BDA forum—his first as an industry participant, where he spoke on a panel about innovative trends in alternative assets.
“In 2015 when we decided to establish an offshore jurisdiction, we had options, but we decided Bermuda was the place for us to do our business. Three years later, we’ve grown from one to 16 people in our Hamilton offices—so, it proves our point,” Bertrand said. “I wanted to share our story that Bermuda is a jurisdiction of choice and a great place in which to complete a global presence. We have several offices around the world, but Bermuda is a very important one for us.”
The Bermuda Tourism Authority (BTA) partnered with the BDA on a networking reception that concluded the forum.
Tomorrow [Wednesday, November 28], the BDA continues the roadshow, staging a dedicated Bermuda Fintech Forum in the morning featuring a chat between the Premier and AIG CEO Brian Duperreault moderated by BDA Interim CEO Sean Moran. In the afternoon, ILS Bermuda hosts Beyond Convergence, a seminar focused on insurance-linked securities, whose global market Bermuda dominates.
The BDA encourages direct investment and helps companies start up, re-locate or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions. Our goal? To make doing business in Bermuda smooth and beneficial.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/53d2a1ad-aea5-4e75-91c3-5ffeefff2377
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Gainsight Unveils the Customer Cloud, the Future of Customer Success Technology23.5.2019 19:30:00 CEST | Pressemelding
New Products Announced at Pulse 2019 to Drive Customer Success Across the Enterprise SAN FRANCISCO, May 23, 2019 (GLOBE NEWSWIRE) -- Today, Gainsight® launched the Customer Cloud —a first-of-its-kind solution for subscription businesses looking to adopt a customer-centric philosophy that enables them to retain customers while also driving company growth post-sale. According to the 2018 Subscription Economy Index report, subscription companies are growing five times faster than S&P and retail sales. The Gainsight Customer Cloud caters to these businesses by combining the company’s Customer Success and Product Experience products with three new product innovations to offer a powerful set of solutions for businesses to optimize their subscription strategies through technology. “With the maturity of cloud technology and the subscription economy, customer expectations have drastically changed. Companies are struggling to leverage existing tools to satisfy the increasing demands of their cus
Lowered Return Expectations Among Several Trends Pointing to a Shift in Private Markets Due Diligence says New eVestment Survey23.5.2019 15:30:00 CEST | Pressemelding
ATLANTA, May 23, 2019 (GLOBE NEWSWIRE) -- Private markets funds have continued to rake in new commitments from institutional investors eager to diversify their portfolios and capture the returns private markets investments can offer. However, investors are now tempering their private markets return expectations. Coupled with other industry trends, this will have implications for private markets fundraising and due diligence according to a new eVestment report, produced in association with parent company Nasdaq. The 2019 eVestment Private Markets Due Diligence Survey of institutional investors, consultants and private markets fund managers finds that 52% of investors expect returns in the space to decline in the future (page 16). Only 12% of investors expected private equity returns to increase, with the balance – 36% – expecting returns to stay about the same. Forty-seven percent of investors surveyed expect to see lower returns in venture capital vs. just 16% of investors who expect r
Collibra Announces 2019 Excellence Awards Winners23.5.2019 15:00:00 CEST | Pressemelding
American Express, Deloitte, and Lloyds Banking Group recognized as leaders in harnessing data to drive digital transformation NEW YORK, May 23, 2019 (GLOBE NEWSWIRE) -- Collibra, the leader in enterprise data governance and catalog software, today announced the winners of the 2019 Collibra Excellence Awards. Presented at the annual Data Citizens conference in New York, the awards honor teams and individuals driving innovative data strategy by collaborating with Collibra. “In today’s market, organizations that are able to maximize data have the power to transform entire industries,” said Felix Van de Maele, co-founder and CEO of Collibra. “We’re proud to honor the recipients of the Collibra Excellence Awards, a cutting-edge group at the forefront of data-driven innovation.” The 2019 Collibra Excellence Award Winners: American Express — Distinguished Data Program of the Year American Express was recognized for its data governance transformation, which began as a compliance initiative and
XBiotech Announces Plan to Launch Randomized Phase 2b Study of Bermekimab in Hidradenitis Suppurativa23.5.2019 14:20:00 CEST | Pressemelding
AUSTIN, Texas, May 23, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced plans to advance its dermatology program for its true human antibody bermekimab with the launch of a randomized, double-blind, placebo controlled, Phase 2b clinical study in patients with moderate to severe Hidradenitis Suppurativa (HS). This Phase 2b study will evaluate safety and efficacy of bermekimab at different subcutaneous doses compared with placebo. The study will further evaluate efficacy of bermekimab in HS and guide dosing strategies for the anticipated Phase 3 registration study. The Company expects the first patient to be enrolled during the third quarter of 2019. The Phase 2b study follows two previous successful clinical studies of bermekimab to treat HS. XBiotech recently evaluated bermekimab in a phase 2 study involving two groups of patients with HS: those who had no prior treatment with biologics; and those who had failed the only approved biological therapy to treat HS. The study, whi
LGC CAPITAL Announces Results of Annual Meeting, Appointment of New Chairman and Approval of Name Change to Elixxer Ltd.23.5.2019 14:00:00 CEST | Pressemelding
MONTRÉAL, May 23, 2019 (GLOBE NEWSWIRE) -- LGC Capital Ltd. (TSXV: LG) (OTCQB: LGGCF) ("LGC" or the “Corporation”) is pleased to announce the results of its annual and special meeting of shareholders (the “Meeting”) held yesterday in Montreal, Quebec. At the Meeting, all five of the nominees listed in the Corporation’s management information circular dated April 17, 2019 were elected as directors, all with a vote of more than 92% of the shares voted in their favour. Accordingly, the directors of LGC for the ensuing year are Mohammed Ghafari, Mazen Haddad, Rafi Hazan, David Lenigas and Ferras Zalt. At the Meeting, shareholders adopted a special resolution approving a change in the name of the Corporation to “Elixxer Ltd.” or such other name as the Corporation’s directors may determine. The special resolution was supported by 98.94% of the votes cast at the Meeting. The Corporation intends to proceed with the name change as expeditiously as possible. Shareholders also adopted: a special
Merus Announces 2019 Annual General Meeting of Shareholders23.5.2019 14:00:00 CEST | Pressemelding
UTRECHT, The Netherlands, May 23, 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, “we”, “our” or the “Company”), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length human bispecific antibody therapeutics, today announced that the 2019 Annual General Meeting of Shareholders will be held on June 12, 2019 at 1:00 pm (CEST) at the offices of NautaDutilh N.V. (address: Beethovenstraat 400, 1082 PR Amsterdam, the Netherlands). All relevant documents and information for the meeting, including the notice and agenda, are available in the 'Investor Relations' section of Merus’ website (www.merus.nl) under “Financial Information”. About Merus N.V. Merus is a clinical-stage immuno-oncology company developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics®. Biclonics®, which are based on the full-length IgG format, are manufactured using industry standard processes and have been observed in preclinical and clin